Inactive Instrument

Calendar KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T2096

End-of-day quote Nasdaq
- USD - Intraday chart for KaloBios Pharmaceuticals Inc

Chart calendar KaloBios Pharmaceuticals Inc

dc33c71634636ad0f9621c1175449592.n9rQdOLp_U7A_6l3H6P3t_5a3osv_1AKVCa7GCm1ogo.8LWoF4igznyVx-sURsmm3tNsmcdtzWBLG2-Jfk_Y1EnSkOEVrIW_GqbO8A~11e3165686444c1d6c9aa5976345f810

Upcoming events on KaloBios Pharmaceuticals Inc

No events available

Past events on KaloBios Pharmaceuticals Inc

13/04/2023 American Association for Cancer Research Meeting
17/11/2022 16:25 Jefferies London Healthcare Conference
13/11/2022 Q3 2022 Earnings Release
28/09/2022 14:00 Cantor Oncology, Hematology & HemeOnc Conference - Panel
12/09/2022 21:00 H.C. Wainwright Global Investment Conference
12/08/2022 21:00 Interim 2022 Earnings Release
21/06/2022 14:00 Lytham Partners Summer Investor Conference
10/06/2022 17:15 Jefferies Healthcare Conference
09/06/2022 18:00 Annual General Meeting
07/06/2022 17:00 LD Micro Invitational XII Conference
24/05/2022 16:00 H.C. Wainwright Global Life Sciences Investment Conference
11/05/2022 13:20 LSX World Congress - Panel
10/05/2022 15:45 LSX World Congress
05/05/2022 21:00 Q1 2022 Earnings Release
27/03/2022 BIO Europe Spring Conference
27/03/2022 MedInvest Pharmaceutical and Biotechnology Investor Conference
16/03/2022 13:20 Oppenheimer Healthcare Conference
15/03/2022 16:00 Roth Capital Partners Conference
04/03/2022 14:00 Oppenheimer March Thought Leadership Series Conference
01/03/2022 08:00 Credit Suisse London Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


0,31
0,00
-
3,60
2,95
22.05%
2,51
2,33
7.9%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-88,2
-93,1
5.22%
-233
-246
5.38%
-68,3
-75,7
9.78%
EBIT
Million USD
Released
Forecast
Spread
0,00


-88,2
-92,6
4.76%
-233
-240
3.11%
-68,3
-80,9
15.58%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-89,5
-94,9
5.67%
-237
-245
3.42%
-70,7
-82,5
14.22%
Net income
Million USD
Released
Forecast
Spread
-10,3


-89,5
-93,8
4.5%
-237
-243
2.48%
-70,7
-82,3
14.06%
EPS
USD
Released
Forecast
Spread
-0,45


-2,42
-1,80
-34.51%
-4,04
-4,12
1.91%
-0,79
-1,02
22.3%
Announcement Date16/03/2010/03/2128/02/2230/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread
0,49
0,00
-
1,04
0,68
51.71%
1,04
0,07
1453.92%
1,04
0,42
146.9%
1,04
0,21
398.08%
1,04
0,35
198.84%
0,22
0,35
-36.25%
0,22
0,10
121%
0,22
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-64,4
-31,3
-105.74%
-70,1
-44,3
-58.13%
-66,0
-68,3
3.4%
-32,3
-51,8
37.53%
-20,5
-35,6
42.33%
-29,4
-20,9
-40.44%
-22,7
-20,2
-12.76%
4,30
-1,88
328.56%



EBIT
Million USD
Released
Forecast
Spread
-64,4
-34,4
-87.42%
-70,1
-48,4
-44.79%
-66,0
-58,3
-13.12%
-32,3
-39,5
18.19%
-20,5
-28,4
27.71%
-29,4
-22,2
-32.51%
-22,7
-11,2
-102.87%
4,30
-8,31
151.74%
-4,24
-17,2
75.38%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-65,6
-27,2
-141.23%
-70,8
-42,6
-66.05%
-66,7
-54,2
-23.18%
-33,5
-48,6
31.04%
-21,3
-31,9
33.3%
-30,1
-22,2
-35.91%
-23,7
-16,3
-45.45%
4,39
-7,57
157.99%
-4,18
-17,2
75.69%
Net income
Million USD
Released
Forecast
Spread
-65,6
-33,6
-95.33%
-70,8
-47,8
-48.23%
-66,7
-56,7
-17.64%
-33,5
-44,4
24.52%
-21,3
-30,0
29.07%
-30,1
-22,4
-34.59%
-23,7
-17,8
-33.11%
4,39
-13,5
132.52%
-4,18
-17,2
75.69%
EPS
USD
Released
Forecast
Spread
-1,25
-0,64
-95.31%
-1,20
-0,83
-44.1%
-1,12
-0,98
-13.71%
-0,53
-0,65
17.93%
-0,32
-0,46
30.93%
-0,43
-0,32
-34.38%
-0,23
-0,19
-22.67%
0,16
-0,06
352.64%
-0,04
-0,06
33.33%
Announcement Date13/05/2112/08/2112/11/2128/02/2205/05/2212/08/2214/11/2230/03/2315/05/23
  1. Stock Market
  2. Equities
  3. HGENQ Stock
  4. Stock
  5. Calendar KaloBios Pharmaceuticals Inc